Biotransplant Researchsp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Biotransplant Research has prepared intestinal flora suspension products for hospitals and medical facilities since 2014. It delivers orders throughout Poland and provides advice and support to healthcare providers.
- Monday–Saturday
- 9:00–17:00
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 77 days late).
- 202524/04/2026
- 202403/06/2025
- 202305/07/2024
- 202222/06/2023
- 202130/09/2022
- 202004/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Gut microbiota preparation
- Intestinal microbiota transplantation
- Preparation delivery
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
- Elementor
- Contact and booking
- Tidio
Public procurement
Biotransplant Research is the contractor in 2 public sector contracts, worth USD 1.08k in total. All of them were signed with the same public buyer.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Sep 24, 2026 | Substrate for performing faecal microbiota transplantation | $540.25 | Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie | |
| Jul 21, 2026 | Substrate for performing faecal microbiota transplantation | $540.25 | Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the company is represented by the President of the Management Board acting independently. In the case of a multi-member management board, the company is represented by the President of the Management Board acting independently, or by two members of the management board, or by one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 78 | $4,213.94 | 78% | |
Others | 22 | $1,188.55 | 22% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-08-18.
62 1240 6670 1111 0010 6054 4365
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 6, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Wrocławia |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Receptonsp. z o.o. | $50,611.05 | receptonbiotech.com | ||
| Biostat Research and Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Unistartsp. z o.o. | $35,872.93 | unistart.pl | ||
| Meditransfer Centrum Transferu Technologii Iitdsp. z o.o. | $35,488.75 | iitd.pan.wroc.pl | ||
| Exomedissp. z o.o. | $26,633.41 | exomedis.com | ||
| Neuro-Opiomelsp. z o.o. | $19,173.50 | neuroopiomel.com | ||
| Biodairy Labssp. z o.o. | $16,811.14 | biodairylabs.com | ||
| Scilosp. z o.o. | $12,634.81 | scilo.eu | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com | ||
| Innosilsp. z o.o. | $7,984.08 | innosil.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-14 | Address change (Ul. Gen. Romualda Traugutta 1-7, 54-449, Wrocław → Ul. Księcia Witolda 43/36, 50-202, Wrocław) | |
| 2015-10-21 | Address change (Wiejska 11 A/13, 52-411, Wrocław → Ul. Gen. Romualda Traugutta 1-7, 54-449, Wrocław) | |
| 2014-09-10 | Entered in the register |
FAQ
Last updated: 2026-05-26